Invention Grant
- Patent Title: Bicyclic peptidyl inhibitors
-
Application No.: US16753681Application Date: 2018-10-04
-
Publication No.: US11339192B2Publication Date: 2022-05-24
- Inventor: Dehua Pei
- Applicant: Ohio State Innovation Foundation
- Applicant Address: US OH Columbus
- Assignee: Ohio State Innovation Foundation
- Current Assignee: Ohio State Innovation Foundation
- Current Assignee Address: US OH Columbus
- Agency: Meunier Carlin & Curfman LLC
- International Application: PCT/US2018/054345 WO 20181004
- International Announcement: WO2019/070962 WO 20190411
- Main IPC: C07K7/64
- IPC: C07K7/64 ; A61P35/00

Abstract:
The present disclosure provides a large combinatorial library of cell-permeable bicyclic peptides. The bicyclic peptides described herein include the first ring consisted of randomized peptide sequences for potential binding to a target of interest while the second ring featured a family of different cell-penetrating motifs, for both cell penetration and target binding. The library was screened against the IκB kinase α/β (IKKα/β)-binding domain of NF-κB essential modulator (NEMO), resulting in the discovery of several cell-permeable bicyclic peptides which inhibited the NEMO-IKKβ interaction, thereby selectively inhibiting canonical NF-κB signaling in mammalian cells and the proliferation of cisplatin-resistant ovarian cancer cells.
Public/Granted literature
- US20200291070A1 BICYCLIC PEPTIDYL INHIBITORS Public/Granted day:2020-09-17
Information query